Drug Is Voluntarily Withdrawn From UK Market

Javelin Pharmaceuticals, a Cambridge developer of acute care pain products, said that a licensee of its Dyloject drug has announced that it is withdrawing all batches of Dyloject from the UK market to ensure patient safety.
boston